Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles

Journal of Immunology

Volumn 170, Issue 1, 2003, Pages 635-642

  Veldman, Christian ^a   Stauber, Angelika ^a   Wassmuth, Ralf ^a   Uter, Wolfgang ^a   Schuler, Gerold ^a   Hertl, Michael ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYTOKINE; DAPSONE; DESMOGLEIN 3; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID;

ADULT; ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HETEROZYGOTE; HLA SYSTEM; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PEMPHIGUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; SKIN DISEASE; TH1 CELL; TH2 CELL;

EID: 0037218618     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.1.635     Document Type: Article

References (38)

1. Amagai, M., V. Klaus-Kovtun, and J. R. Stanley. 1991. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67:869.
2. Hertl, M., and C. Veldman. 2001. Pemphigus: Paradigm of autoantibody-mediated autoimmunity. Skin Pharmacol. Appl. Skin Physiol. 14:408.
3. Hertl, M. 2000. Humoral and cellular autoimmunity in autoimmune bullous skin disorders. Int. Arch. Allergy Clin. Immunol. 122:91.
4. Bhol, K., K, Natarajan, N. Nagarwalla, A. Mohimen, V. Aoki, and A. R. Ahmed. 1995. Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: A model for autoimmunity. Proc. Natl. Acad. Sci. USA 92:5239.
5. Ahmed, A. R., A. Mohimen, and A. J. Yunis. 1993. Linkage of pemphigus vulgaris antibody to the mayor histocompatibility complex in healthy relatives of patients. J. Exp. Med. 177:419.
6. Ahmed, A. R., E. J. Yunis, K. Kharti, R. Wagner, G. Notani, Z. Awdeh, and C. A. Alper. 1990. Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris. Proc. Natl. Acad. Sci. USA 87:7658.
7. Ahmed, A. R., R. Wagner, and K. Khari. 1991. Mayor histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris. Proc. Natl. Acad. Sci. USA 88:5056.
8. Niizeki, H., H. Inoko, H. Narimatsu, H. Takata, A. Sonoda, T. Tadakuma, A. Ando, K. Tsuji, T. Hashimoto, and T. Nishikawa. 1991. HLA class II antigens are associated with Japanese pemphigus patients. Hum. Immunol. 31:246.
9. Sinha, A. A., C. Brautbar, F. Szafer, A. Friedmann, E. Tzfoni, J. A. Todd, L. Steinman, and H. O. McDevitt. 1988. A newly characterized HLA-DQβ allele associated with pemphigus vulgaris. Science 239:1026.
10. Matzner, Y., H. A. Erlich, C. Brautbar, A. Sanilevitch, M. Landau, S. Brenner, and A. Friedman. 1995. Identical HLA class II alleles predispose to drug-triggered and idiopathic pemphigus vulgaris. Acta Derm. Venereol. 75:12.
11. Wucherpfennig, K., and J. L. Strominger. 1995a. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: A mechanism for MHC-linked susceptibility to human autoimmune diseases. J. Exp. Med. 181:1597.
12. Lin, M. S., S. J. Swartz, A. Lopez, X. Ding, M. A. Fernandez-Vina, P. Stastny, J. A. Fairley, and L. Diaz. 1997. Development and characterization of desmoglein 3-specific T cells from patients with pemphigus vulgaris. J. Clin. Invest. 99:31.
13. Heal, M., M. Amagai, H. Sundaram, J. Stanley, K. Ishii, and S. I. Katz. 1998. Recognition of desmoglein3 by autoreactive T cells in pemphigus vulgaris patients and normals. J. Invest. Dermatol. 110:62.
14. Riechers, R., J. Grötzinger, and M. Hertl. 1999. HLA class II restriction of autoreactive T cell responses in pemphigus vulgaris and potential applications for a specific immunotherapy. Autoimmunity 30:183.
15. Lin, M. S., C. L. Fu, V. Aoki, G. Hans-Filho, E. A. Rivitti, J. R. Moraes, M. E. Moraes, A. M. Lazaro, G. J. Giudice, P. Stastny, and L. A. Diaz. 2000. Desmoglein-1-specific T lymphocytes from patients with endemic pemphigus foliaceus (fogo selgagem). J. Clin. Invest. 105:207.
16. Eming, R., L. Büdinger, R. Riechers, O. Christensen, H. Bohlen, R. Kalish, and M. Hertl. 2000. Frequency analysis of autoreactive T helper 1 and 2 cells in bullous pemphigoid and pemphigus vulgaris by ELISPOT analysis. Br. J. Dermatol. 143:1279.
17. Wucherpfennig, K. W., B. Yu, K. Bhol, D. S. Monos, E. Argyris, R. W. Karr, A. R. Ahmed, and J. L. Strominger. 1995b. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: Charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc. Natl. Acad. Sci. USA 92:11935.
18. Nishifuyi, K., M. Amagai, M. Kuwana, T. Iwasaki, and T. Nishikawa. 2000. Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: Requirement of T cell collaboration for autoantibody production. J. Invest. Dermatol. 114:188.
19. Tsunoda, K., T. Ota, H. Suzuki, M. Okyama, T. Nagai, T. Nishikawa, M. Amagai, and S. Koyasu. 2002. Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris. Eur. J. Immunol. 32:627.
20. Ishii, K., M. Amagai, R. P. Hall, T. Hashimoto, A. Takayanagi, S. Gamou, N. Shimizu, and T. Nishikawa. 1997. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J. Immunol. 159:2010.
21. Manz, R., M. Assenmacher, E. Pfluger, S. Miltenyi, and A. Radbruch. 1995. Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix. Proc. Natl. Acad. Sci. USA 92:1921.
22. Büdinger. L., L. Borradori, C. Yee. R. Eming, S. Ferencik, H. Grosse-Wilde, H. F. Merk, K. Yancey, and M. Hertl. 1998. Identification and characterization of autoreactive T cell responses to bullous pemphigoid (BP) antigen 2 in patients with BP and HLA-DQB1*0301 positive normals. J. Clin. Invest. 102:2082.
23. Hertl, M., R. W. Karr, M. K. Amagai, and S. I. Katz. 1998. Heterogeneous MHC II restriction pattern of auto-reactive desmoglein 3 specific T cell responses in pemphigus vulgaris patients and normals. J. Invest. Dermatol. 110:388.
24. Spaeth, S., R. Riechers, L. Borradori, D. Zillikens, L. Büdinger, and M. Hertl. 2002. Autoantibodies of various isotypes (IgG, IgA, IgE) against desmoglein 3 in patients with active pemphigus vulgaris. Br. J. Dermatol. 146:189.
25. Baas, A., X. Gao, and G. Chelvanayagam. 1999. Peptide binding motifs and specificities for HLA-DQ molecules. Immunogenetics 50:8.
26. Burns, J., A. Rosenzweig, B. Zweiman, and R. P. Lisak. 1983. Isolation of myelin basic protein-reactive T cell lines from normal human blood. Cell Immunol. 81:435.
27. Fredrikson, S., J. B. Sun, W. H. Huang, B. L. Li, T. Olsson, and H. Link. 1993. Cord blood contains high numbers of autoimmune T cells recognizing multiple myelin proteins and acetylcholine receptor. J. Immunol. 151:2217.
28. Tejada-Simon, M. V., J. Hong, V. M. Rivera, and J. Z. Zhang. 2001. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals. Eur. J. Immunol. 31:907.
29. Kuwana, M., C. A. Feghali, T. A. Medsger, and T. M. Wright. 2001. Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis. Arthritis Rheum. 44:1654.
30. Goebels, N., H. Hofstetter, S. Schmidt, C. Brunner, H. Wekerle, and R. Hohlfeld, 2000. Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: Epitope spreading versus clonal persistence. Brain 123:508.
31. Pender, M. P., P. A. Csurhes, J. M. Greer, P. D. Mowat, R. D. Henderson, K. D. Cameron, D. M. Purdie, P. A. McCombe, and M. F. Good. 2000. Surges of increased T cell reactivity to an encephalitogenic region of myelin proteolipid protein occur more often in patients with multiple sclerosis than in healthy subjects. J. Immunol. 165:5322.
32. Kita, H., S. Matsumura. X.-S. He. A. A. Ansari, Z.-X. Lian. J. Van de Water, R. L. Coppel, M. M. Kaplan, and M. E. Gershwin. 2002. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J. Clin. Invest. 109:1231.
33. Mysliwiec, J., A. Kretowski, J. Topolska, K. Siewko, D. Jakubczyk, M. Szelachowska, A. Mikita, and I. Kinalska. 2001. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' opthalmopathy treated with corticosteroids. Horm. Metab. Res. 33:739.
34. Braun, C. M., S. K. Huang, G. G. Bashian, A. Kagey-Sobotka, L. M. Lichtenstein, and D. M. Essayan. 1997. Corticosteroid modulation of human, antigen-specific Th1 and Th2 responses. J. Allergy Clin. Immunol. 100:400.
35. Kuwana, M., T. A. Medsger, and T. M. Wright. 2000. Analysis of soluble and cell surface factors regulating anti-DNA topoisomerase I autoantibody production demonstrates synergy between Th1 and Th2 autoreactive T cells. J. Immunol. 164:6138.
36. Voll, R. E., E. A. Roth, I. Girkontaite, H. Fehr, M. Herrmann, H.-M. Lorentz, and J. R. Kalden. 1997. Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production. Arthritis Rheum. 40:2162.
37. + lymphocytes by soluble major histocompatibility complex class II-peptide complexes. J. Clin. Invest. 93:1361.
38. Atassi, M. Z., and M. Oshima. 2001. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides. Crit. Rev. Immunol. 17:481.